PASG Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Progress AMBR Q4 2025 Earnings Modest EPS Miss Meets Positive Stock Momentum Monte Rosa Therapeutics Inc GLUE Q1 2026 Earnings WiderthanExpected Loss Compounds Investor Caution UBCP Q4 2022 Earnings Solid EPS Performance Drives Positive Stock Movement Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises